For individuals battling Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a debilitating condition, the arrival of this treatment and the formulated version represents a true change. These novel therapies protect the transthyretin protein, halting its harmful build-up and reducing the … Read More